BioScience Health Innovations, Inc. financial data

Symbol
BHIC on OTC
Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 27 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 15.7 % -50.3%
Return On Equity 64.1 % +177%
Return On Assets 55.4 % +214%
Operating Margin 18.7 % +646%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11M shares -73.9%
Common Stock, Shares, Outstanding 11M shares -73.9%
Entity Public Float 41.6M USD
Common Stock, Value, Issued 1.1K USD -73.9%
Weighted Average Number of Shares Outstanding, Basic 11M shares +4.82%
Weighted Average Number of Shares Outstanding, Diluted 11M shares +0.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.73M USD +207%
Research and Development Expense 37.5K USD +4563%
Operating Income (Loss) 886K USD +2191%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 886K USD +2191%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.14M USD +242%
Accounts Receivable, after Allowance for Credit Loss, Current 63.2K USD +98.1%
Inventory, Net 758K USD +1694%
Assets, Current 1.99M USD +388%
Intangible Assets, Net (Excluding Goodwill) 72.1K USD +925%
Assets 2.07M USD +397%
Accounts Payable, Current 10.2K USD +20.3%
Accrued Liabilities, Current 6.69K USD +167%
Liabilities 356K USD +682%
Retained Earnings (Accumulated Deficit) 535K USD
Stockholders' Equity Attributable to Parent 1.71M USD +362%
Liabilities and Equity 2.07M USD +397%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 328K USD
Net Cash Provided by (Used in) Financing Activities 67.5K USD -44.5%
Net Cash Provided by (Used in) Investing Activities -30K USD
Common Stock, Shares Authorized 250M shares +233%
Common Stock, Shares, Issued 11M shares -73.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.14M USD +242%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 49K USD -33.1%
Deferred Tax Assets, Operating Loss Carryforwards 47.4K USD -5.43%
Preferred Stock, Shares Issued 140K shares 0%
Preferred Stock, Shares Authorized 140K shares 0%
Additional Paid in Capital 1.18M USD +63.9%
Preferred Stock, Shares Outstanding 140K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 0 USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%